Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aged 60 Years or Older”

45 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 45 results

Not applicableEnded earlyNCT02485353
What this trial is testing

Study of Vosaroxin and Cytarabine for the Treatment of Adults 60 Years of Age or Older With Previously Untreated AML

Who this might be right for
Leukemia, Myeloid, Acute
Hamid Sayar 2
Not applicableUnknownNCT05704660
What this trial is testing

Automatic Reaction to Physical Activity and Sedentary Stimuli in Aging

Who this might be right for
Aging
University of Ottawa 216
Not applicableStudy completedNCT02663726
What this trial is testing

Adapted Yoga for Inactive Older Adults

Who this might be right for
The Study Will Recruit Adults Aged 60 Years or Older
Northumbria University 52
Not applicableStudy completedNCT04117113
What this trial is testing

Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli-2 (EXPECT-2)

Who this might be right for
E. Coli Infection
UMC Utrecht 238
Testing effectiveness (Phase 2)Study completedNCT00839982
What this trial is testing

Clofarabine and Cytarabine in Treating Older Patients With AML or High-Risk MDS

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+5 more
Fred Hutchinson Cancer Center 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT02758717
What this trial is testing

Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma

Who this might be right for
Ann Arbor Stage IB Hodgkin LymphomaAnn Arbor Stage II Hodgkin LymphomaAnn Arbor Stage IIA Hodgkin Lymphoma+8 more
Academic and Community Cancer Research United 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07507760
What this trial is testing

Oral Decitabine Plus Ivosidenib as First Line for Older/Unfit Adult AML Patients

Who this might be right for
Acute Myeloid Leukemia With Gene Mutations
PETHEMA Foundation 50
Not applicableNot Yet RecruitingNCT06961812
What this trial is testing

Validation of the Self-Assessment for Falls in the Elderly (SAFE) Questionnaire to Assess the Risk of Falls in People Aged 60 or Over.

Who this might be right for
Fall PreventionFalls (Accidents) in Old Age
University Hospital, Montpellier 300
Early research (Phase 1)WithdrawnNCT02647190
What this trial is testing

Intravenous Erwinia Chrysanthemi Asparaginase in Patients With Newly Diagnosed Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Aged 60 Years or Older

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Newly Diagnosed Philadelphia Chromosome NegativeAged 60 Years or Older
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT07505693
What this trial is testing

The Effect of Health Belief Model-Based Education on Knowledge and Behavioral Changes Regarding Dementia in Older Adults

Who this might be right for
Aged 60 Years or OlderVolunteering to Participate in the StudyDementia Education+1 more
Hasan Kalyoncu University 66
Not applicableUnknownNCT03434938
What this trial is testing

IMAGINE Study Protocol

Who this might be right for
Patients (>=60 Years Old) Suffering From Mild-moderate Stroke (Ischemic or Hemorrhagic, Stroke Severity Assessed by NIHSS <16 Points)
Parc Sanitari Pere Virgili 272
Early research (Phase 1)Study completedNCT01804205
What this trial is testing

Magnesium Sulphate and Rocuronium in Patients Over 60

Who this might be right for
Head and Neck Cancer
Pedro Rotava 64
Testing effectiveness (Phase 2)Study completedNCT00073931
What this trial is testing

Iodine I 131 Tositumomab Followed by Autologous Stem Cell Transplantation in Treating Older Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Fred Hutchinson Cancer Center 25
Not applicableStudy completedNCT04087681
What this trial is testing

Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli (EXPECT-1)

Who this might be right for
E.Coli Infections
MJM Bonten 4,479
Testing effectiveness (Phase 2)Study completedNCT03814590
What this trial is testing

Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older Adults

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 1,053
Not applicableLooking for participantsNCT06974006
What this trial is testing

Life Monitoring for Rural Older Adults

Who this might be right for
Aged 60 Years or Older
European University Miguel de Cervantes 82
Testing effectiveness (Phase 2)UnknownNCT04541277
What this trial is testing

Combined Inhibition of PD-1 and DNA Hypomethylating Agent +/- Chemotherapy in High-risk AML or Elderly Patients With AML Who Are Unfit for Intensive Chemotherapy

Who this might be right for
Acute Myeloid Leukemia, in Relapsed or RefractoryAcute Myeloid Leukemia, Elderly, UnfitAcute Myeloid Leukemia With Positive Minimal Residual Disease
Chinese PLA General Hospital 55
Not applicableNot Yet RecruitingNCT07162103
What this trial is testing

Group Mandala Art Therapy for Well-Being and Loneliness in the Elderly (GEMEL-WB:RCT)

Who this might be right for
Elderly Individuals Aged 60 Years or Older
Suleyman Demirel University 58
Early research (Phase 1)Study completedNCT06237296
What this trial is testing

Study of the Safety and Immune Response of an Investigational mRNA Vaccine for the Prevention of Respiratory Syncytial Virus and/or Human Metapneumovirus in Participants Aged 18 to 49 Years and 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus InfectionHealthy VolunteersMetapneumovirus Infection
Sanofi Pasteur, a Sanofi Company 558
Not applicableStudy completedNCT06604390
What this trial is testing

THE EFFECTS OF GAMBIR CATECHIN (UNCARIA GAMBIR ROXB) SUPPLEMENTATION ON COGNITIVE FUNCTION, EXPRESSION OF APP, MAPT, BDNF, IL-10, TGF-Β GENES, AND PLASMA MDA LEVELS IN THE ELDERLY.

Who this might be right for
Elderly Individuals Aged 60 Years or OlderMild Cognitive Impairment (MCI)
Rahmi Novita Yusuf 64
Load More Results